Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Levomin
- Development stage
- Unknown
- Lead developer
- DermaPharm
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Levomin is a combined oral contraceptive (COC) containing the synthetic estrogen ethinylestradiol and the synthetic progestin levonorgestrel. Developed by Mibe Arzneimittel, it is approved and marketed in strengths of 20/100 µg (Levomin 20) and 30/150 µg (Levomin 30). The medication works primarily by suppressing ovulation through the inhibition of gonadotropin secretion (luteinizing hormone and follicle-stimulating hormone) from the pituitary gland. Additionally, it thickens cervical mucus to inhibit sperm penetration and alters the endometrium to reduce the likelihood of implantation, providing reliable prevention of pregnancy.
- Brand names
- LevominLevomin 20Levomin20Levomin-20Levomin 20/100Levomin 30Levomin30Levomin-30Levomin 30/150
- Other names
- EE/LNGethinyl estradiol + levonorgestrelethinylestradiol + levonorgestrellevonorgestrel + ethinyl estradiollevonorgestrel + ethinylestradiol
02
Targets
ESR1 (ERα)ESR2 (ERβ)PR (Progesterone receptor)
Beyond the preview
Go deeper on Levomin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Levomin.